Summary: The FDA has awarded a $1.6 million, four-year grant to Debra Weese-Mayer, MD, of Lurie Children’s Hospital for a study on congenital central hypoventilation syndrome. The study will aim to establish clinical, functional, and quality-of-life measures that correlate with … [Read more...]
Apnimed to Showcase Study Findings on Obesity Hypoventilation Syndrome
Summary: Apnimed Inc, a clinical-stage pharmaceutical company developing oral therapies for obstructive sleep apnea and other sleep disorders, will showcase findings from a recent clinical trial on obesity hypoventilation syndrome (OHS) at the European Respiratory Society (ERS) … [Read more...]